A detailed history of Apg Asset Management Us Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Apg Asset Management Us Inc. holds 7,705 shares of MRNA stock, worth $262,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,705
Previous 27,865 72.35%
Holding current value
$262,432
Previous $3.31 Million 84.46%
% of portfolio
0.0%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$63.64 - $125.14 $1.28 Million - $2.52 Million
-20,160 Reduced 72.35%
7,705 $514,000
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $1.35 Million - $2.22 Million
-13,334 Reduced 32.36%
27,865 $3.31 Million
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $1.83 Million - $2.48 Million
-21,456 Reduced 34.24%
41,199 $4.39 Million
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $4.36 Million - $6.54 Million
62,655 New
62,655 $6.23 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $13.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Apg Asset Management Us Inc. Portfolio

Follow Apg Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management Us Inc. with notifications on news.